Deep, qualified following-generation sequencing has discovered that subclonal mutations (i.e., Individuals current in only a fraction of tumor cells) is often detected for all driver genes and they are associated with fast illness progression and poor final result.11–thirteen This is particularly appropriate for TP53 See "Qualified therapies in CLL: mechanisms https://herbertw630dhk0.blogtov.com/profile